HLA-A*02:01 structures
343 items
Page 7 of 14 | 25 items per page | ordered by release date, descending
1 2 3 4 5 6 7 8 9 10 11 12 13 14| 5EU4 |
HLA-A*02:01 binding "YLAPGPVTA" at 2.12Å resolution |
| 4WUU |
HLA-A*02:01 binding "RMFPNAPYL" with antibody at 3.05Å resolution |
| 5D2L |
HLA-A*02:01 presenting "NLVPMVATV" to Alpha/Beta T cell receptor at 3.51Å resolution |
| 5D2N |
HLA-A*02:01 presenting "NLVPMVATV" to Alpha/Beta T cell receptor at 2.10Å resolution |
| 4U6Y |
HLA-A*02:01 binding "FLNKDLEVDGHFVTM" at 1.47Å resolution |
| 4U6X |
HLA-A*02:01 binding "ALQDAGDSSRKEYFI" at 1.68Å resolution |
| 4NO3 |
HLA-A*02:01 binding "RQISQDVKL" at 1.70Å resolution |
| 4NO5 |
HLA-A*02:01 binding "RQISQDVKL" at 2.10Å resolution |
| 4QOK |
HLA-A*02:01 presenting "EAAGIGILTV" to Alpha/Beta T cell receptor at 3.00Å resolution |
| 4NO2 |
HLA-A*02:01 binding "RQASIELPSMAV" at 2.00Å resolution |
| 4NNY |
HLA-A*02:01 binding "RQASLSISV" at 1.90Å resolution |
| 4NNX |
HLA-A*02:01 binding "RQASLSISV" at 2.10Å resolution |
| 4NO0 |
HLA-A*02:01 binding "RQASIELPSMAV" with LIR-1 NK receptor at 2.70Å resolution |
| 4WJ5 |
HLA-A*02:01 binding "XVAGIGILTX" at 1.65Å resolution |
| 4UQ3 |
HLA-A*02:01 binding "GLSXXL" at 2.10Å resolution |
| 4L3E |
HLA-A*02:01 presenting "ELAGIGILTV" to Alpha/Beta T cell receptor at 2.56Å resolution |
| 4L29 |
HLA-A*02:01 binding "YLLMWITQV" at 3.09Å resolution |
| 4L3C |
HLA-A*02:01 binding "YLLMWITQV" at 2.64Å resolution |
| 4MNQ |
HLA-A*02:01 presenting "ILAKFLHWL" to Alpha/Beta T cell receptor at 2.74Å resolution |
| 4FTV |
HLA-A*02:01 presenting "LLFGYPVYV" to Alpha/Beta T cell receptor at 2.74Å resolution |
| 4K7F |
HLA-A*02:01 binding "VCWGELMNL" at 2.00Å resolution |
| 4JFQ |
HLA-A*02:01 binding "ELAGIGIATV" at 1.90Å resolution |
| 4JFO |
HLA-A*02:01 binding "ALAGIGILTV" at 2.11Å resolution |
| 4JFP |
HLA-A*02:01 binding "ELAAIGILTV" at 1.91Å resolution |
| 4JFD |
HLA-A*02:01 presenting "ELAAIGILTV" to Alpha/Beta T cell receptor at 2.46Å resolution |
1 2 3 4 5 6 7 8 9 10 11 12 13 14

This work is licensed under a Creative Commons Attribution 4.0 International License.